HSBC Holdings
SLDB icon

HSBC Holdings’s Solid Biosciences SLDB Stock Holding History

HSBC Holdings’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$284K Buy
39,511
+17,360
+78% +$112K ﹤0.01% 2469
2025
Q4 		$127K Sell
22,151
-1,441
-6% -$7.81K ﹤0.01% 2765
2025
Q3 		$138K Sell
23,592
-1,787
-7% -$10.4K ﹤0.01% 2558
2025
Q2 		$126K Buy
25,379
+6,311
+33% +$22.3K ﹤0.01% 2803
2025
Q1 		$69.8K Buy
19,068
+91
+0.5% +$390 ﹤0.01% 2862
2024
Q4 		$75.1K Buy
18,977
+2,464
+15% +$13.5K ﹤0.01% 2934
2024
Q3 		$115K Buy
+16,513
New +$134K ﹤0.01% 2775
2022
Q4 		– Sell
-2,700
Closed -$21K – 3184
2022
Q3 		$21K Sell
2,700
-882
-25% -$8.89K ﹤0.01% 2870
2022
Q2 		$34K Hold
3,582
– – ﹤0.01% 3167
2022
Q1 		$64K Hold
3,582
– – ﹤0.01% 3179
2021
Q4 		$94K Buy
3,582
+1,586
+79% +$48.5K ﹤0.01% 3148
2021
Q3 		$72K Buy
+1,996
New +$84.8K ﹤0.01% 2913

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

HSBC Holdings's SLDB Position: Q1 2026 in Review

HSBC Holdings increased its Solid Biosciences (SLDB) stake by 78% in Q1 2026, buying an estimated $112K and bringing the position to 39,511 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #2469.

HSBC Holdings first reported a position in SLDB in Q3 2021 and has held it in 12 quarters since. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • HSBC Holdings held 39,511 shares of Solid Biosciences worth $284K as of Q1 2026.
  • HSBC Holdings bought 17,360 Solid Biosciences shares in Q1 2026, an estimated $112K.
  • Solid Biosciences made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2469 holding.
  • HSBC Holdings first reported a position in Solid Biosciences in Q3 2021 and has held it in 12 quarters since.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.